BMW Sold More Cars Than Ever in 2023
By David Sachs
BMW Group sold more cars in 2023 than it ever has over a one-year period, crediting close cooperation with retailers and strong performances by sales associates.
The German carmaker said Tuesday that group sales approached 2.6 million last year, a 6.5% increase over 2022, breaking its all-time record. Sales grew 10% in the fourth quarter to around 718,800, BMW said.
The company also hit its annual fully-electric vehicle sales target, with 15% of sales comprising battery-powered vehicles last year. Group-wide, EV sales reached almost 376,200 in 2023, a 74% hike from last year.
BMW confirmed its EV sales target of more than 500,000 in 2024 despite analysts expecting softer demand.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
January 09, 2024 03:47 ET (08:47 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track